Literature DB >> 11792562

Regulating DeltaFosB expression in adult Tet-Off-DeltaFosB transgenic mice alters bone formation and bone mass.

N A Sims1, G Sabatakos, J-S Chen, M B Kelz, E J Nestler, R Baron.   

Abstract

The DeltaFosB isoforms are naturally occurring AP-1 family members that increase bone volume via a cell-autonomous effect on osteoblastic bone formation. Mice overexpressing DeltaFosB demonstrate a very high level of bone formation, resulting in a progressive osteosclerosis. Despite the linkage of bone formation and resorption in physiological systems, no alteration in bone resorption was detected in mice overexpressing DeltaFosB. To determine whether altering DeltaFosB expression can regulate bone formation independently of bone resorption in adult mice, we used the Tet-Off-inducible transgene system to induce or block transgenic DeltaFosB overexpression and thereby regulate bone formation in vivo. Overexpression of DeltaFosB after skeletal maturity increased trabecular bone volume by increasing bone formation, again without altering bone resorption, indicating that developmental DeltaFosB overexpression is not required for the osteosclerotic phenotype. Similarly, switching off DeltaFosB overexpression after osteosclerosis had developed led to a marked decrease in bone formation and loss of bone mass such that trabecular bone volume approached normal levels. Despite this dramatic reduction, no alteration in bone resorption was detected. These results clearly demonstrate that DeltaFosB regulates bone formation and bone mass in adult mice with no effect on bone resorption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792562     DOI: 10.1016/s8756-3282(01)00622-6

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

1.  Sequence-specific DNA binding by the alphaNAC coactivator is required for potentiation of c-Jun-dependent transcription of the osteocalcin gene.

Authors:  Omar Akhouayri; Isabelle Quélo; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 2.  Molecular mechanisms underlying the effects of sex steroids on bone and mineral metabolism.

Authors:  Yuuki Imai; Takashi Nakamura; Takahiro Matsumoto; Kunio Takaoka; Shigeaki Kato
Journal:  J Bone Miner Metab       Date:  2009-01-29       Impact factor: 2.626

3.  Activation of the transcription factor FosB/activating protein-1 (AP-1) is a prominent downstream signal of the extracellular nucleotide receptor P2RX7 in monocytic and osteoblastic cells.

Authors:  Monica L Gavala; Lindsay M Hill; Lisa Y Lenertz; Maya R Karta; Paul J Bertics
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

4.  Energy expenditure and bone formation share a common sensitivity to AP-1 transcription in the hypothalamus.

Authors:  Glenn C Rowe; Vincent Vialou; Kazusa Sato; Hiroaki Saito; Min Yin; Thomas A Green; Sutada Lotinun; Marie Kveiborg; William C Horne; Eric J Nestler; Roland Baron
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

5.  ΔFOSB: A Potentially Druggable Master Orchestrator of Activity-Dependent Gene Expression.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  ACS Chem Neurosci       Date:  2022-01-12       Impact factor: 4.418

6.  Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity.

Authors:  George Sabatakos; Glenn C Rowe; Marie Kveiborg; Meilin Wu; Lynn Neff; Riccardo Chiusaroli; William M Philbrick; Roland Baron
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

7.  DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms.

Authors:  Marie Kveiborg; George Sabatakos; Riccardo Chiusaroli; Meilin Wu; William M Philbrick; William C Horne; Roland Baron
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia.

Authors:  J Peng; M Bencsik; A Louie; W Lu; S Millard; P Nguyen; A Burghardt; S Majumdar; T J Wronski; B Halloran; B R Conklin; R A Nissenson
Journal:  Endocrinology       Date:  2007-11-29       Impact factor: 4.736

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.